OptimizeRx Corp OPRX
Nasdaq · stock · Services-Business Services, NEC · website · IPO 2005-05-18
OptimizeRx Corp financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109.4M | $92.1M | $71.5M | — | $62.5M | $61.3M | $43.3M | $24.6M | $21.2M | $12.1M |
| Gross profit | $73.6M | $59.4M | $42.9M | — | $39.0M | $35.6M | $24.1M | $15.4M | $12.2M | $6.0M |
| R&D expense | $0 | $0 | — | — | — | — | $0 | $1.6M | $0 | — |
| SG&A expense | — | — | — | — | $33.5M | $27.7M | — | — | — | — |
| Operating income | $11.7M | -$13.7M | -$26.4M | — | -$12.3M | $361,100 | -$2.1M | -$3.7M | $180,132 | -$2.1M |
| Interest expense | — | — | $1.5M | — | — | — | — | — | — | — |
| Income tax | $1.8M | $725,000 | -$7.6M | — | — | — | — | -$897,960 | — | — |
| Net income | $5.1M | -$20.1M | -$17.6M | — | -$11.4M | $378,079 | -$2.2M | -$3.1M | $226,344 | -$2.1M |
| EPS (diluted) | $0.27 | $-1.10 | $-1.03 | $-0.21 | $-0.64 | $0.02 | $-0.15 | $-0.23 | $0.02 | $-0.21 |
| Operating cash flow | $18.7M | $4.9M | -$7.2M | — | $10.7M | $726,039 | -$6.3M | -$1.7M | $792,555 | -$1.5M |
| Free cash flow | $18.7M | $4.8M | -$7.3M | — | $10.6M | $625,717 | -$6.4M | -$1.7M | $758,193 | -$1.5M |
| Cash & equivalents | $23.4M | $13.4M | $13.9M | $9.8M | $18.2M | $84.7M | $10.5M | $18.9M | $8.9M | $5.1M |
| Total assets | $176.9M | $171.2M | $183.4M | $121.3M | $134.7M | $141.0M | $60.3M | $56.6M | $25.1M | $9.8M |
| Total liabilities | $48.6M | $54.2M | $56.8M | $5.5M | $8.5M | $9.6M | $10.4M | $11.8M | $6.6M | $3.5M |
| Shareholders' equity | $128.3M | $117.0M | $126.6M | $115.8M | $126.1M | $131.4M | $50.0M | $44.9M | $18.5M | $6.2M |
Growth · year-over-year · Revenue CAGR 31.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +18.8% | +28.8% | — | — | +1.9% | +41.5% | +76.1% | +16.0% | +74.9% | +56.5% |
| Net income growth | — | — | — | — | -3125.4% | — | — | -1488.4% | — | — |
| EPS growth | — | — | — | — | -3300.0% | — | — | -1250.0% | — | — |
| Free cash flow growth | +290.6% | — | — | — | +1589.8% | — | — | -330.6% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.